8457 related articles for article (PubMed ID: 1535986)
1. TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells.
Palmieri G; Morrone S; Lollini PL; De Giovanni C; Nicoletti G; Nanni P; Frati L; Santoni A
Scand J Immunol; 1992 Mar; 35(3):279-87. PubMed ID: 1535986
[TBL] [Abstract][Full Text] [Related]
2. Inverse relationship in H-2-associated lysis between NK cells and rIL-2-activated killer cells: evidence from in vitro killing and metastatic experiments.
Toshitani A; Taniguchi K; Kawano Y; Nomoto K
Cell Immunol; 1987 Aug; 108(1):188-202. PubMed ID: 3496972
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
Yang H; Dithmar S; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vivo sensitivity of in vitro interferon-treated B16 melanoma cells to CD8 cells and activated macrophages.
Fleischmann CM; Stanton GJ; Fleischmann WR
J Interferon Cytokine Res; 1996 Oct; 16(10):805-12. PubMed ID: 8910765
[TBL] [Abstract][Full Text] [Related]
5. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
Kawano Y; Taniguchi K; Toshitani A; Nomoto K
J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
[TBL] [Abstract][Full Text] [Related]
6. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
Kim TS; Xu WS; Sun T; Cohen EP
Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
8. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
[TBL] [Abstract][Full Text] [Related]
9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
12. Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.
Taniguchi K; Kärre K; Klein G
Int J Cancer; 1985 Oct; 36(4):503-10. PubMed ID: 4044058
[TBL] [Abstract][Full Text] [Related]
13. Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells.
De Giovanni C; Palmieri G; Nicoletti G; Landuzzi L; Scotlandi K; Bontadini A; Tazzari PL; Sensi M; Santoni A; Nanni P
Int J Cancer; 1991 May; 48(2):270-6. PubMed ID: 1902202
[TBL] [Abstract][Full Text] [Related]
14. Anti-metastatic effect by in vivo administration of concanavalin A through augmentation of T-derived activated killer activity: efficacy to B16 melanoma expressed MHC antigen.
Taniguchi K; Kawano YI; Toshitani A; Karashima A; Nomoto K
Cell Immunol; 1989 May; 120(2):460-9. PubMed ID: 2785862
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
[TBL] [Abstract][Full Text] [Related]
16. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
17. Characterization of effector cells against B16 melanoma in mice inoculated with allogeneic spleen cells.
Nishi Y; Hosokawa T; Aoike A; Han D; Takehara H; Kawai K; Kamahora T
Microbiol Immunol; 1994; 38(3):217-23. PubMed ID: 7915815
[TBL] [Abstract][Full Text] [Related]
18. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells.
McMillan TJ; Rao J; Everett CA; Hart IR
Int J Cancer; 1987 Nov; 40(5):659-63. PubMed ID: 2445702
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.
Lollini PL; De Giovanni C; Nicoletti G; Bontadini A; Tazzari PL; Landuzzi L; Scotlandi K; Nanni P
Clin Exp Metastasis; 1990; 8(2):215-24. PubMed ID: 2107993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
